Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
- About
Syra Health Corp. Class A Common Stock (SYRA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
02/24/2026: SYRA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.19M USD | Price to earnings Ratio - | 1Y Target Price 1.8 |
Price to earnings Ratio - | 1Y Target Price 1.8 | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 |
52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.43% | Operating Margin (TTM) -25.48% |
Management Effectiveness
Return on Assets (TTM) -42.21% | Return on Equity (TTM) -94.29% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -1166862 | Price to Sales(TTM) 0.15 |
Enterprise Value -1166862 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.5 | Enterprise Value to EBITDA - | Shares Outstanding 11339200 | Shares Floating 8861182 |
Shares Outstanding 11339200 | Shares Floating 8861182 | ||
Percent Insiders 13.48 | Percent Institutions 1.49 |
Upturn AI SWOT
Syra Health Corp. Class A Common Stock
Company Overview
History and Background
Syra Health Corp. (SYRA) is a health-tech company focused on providing innovative solutions for the healthcare industry. While specific founding year and detailed historical milestones for Syra Health Corp. Class A Common Stock are not readily available in public domain, the company aims to leverage technology to improve healthcare access, efficiency, and patient outcomes. Its evolution likely involves developing and deploying various digital health platforms and services.
Core Business Areas
- Telehealth Services: Providing remote medical consultations, diagnosis, and treatment through digital platforms.
- AI-Powered Health Solutions: Developing and implementing artificial intelligence tools for diagnostics, personalized treatment plans, and operational efficiency in healthcare.
- Digital Health Platforms: Creating and managing software solutions for electronic health records, patient engagement, and healthcare management.
Leadership and Structure
Information regarding the specific leadership team and detailed organizational structure of Syra Health Corp. Class A Common Stock is not publicly detailed. Typically, such companies are led by a CEO, COO, CTO, and CFO, with various departments overseeing operations, technology development, sales, and marketing.
Top Products and Market Share
Key Offerings
- Description: A comprehensive digital health platform offering telehealth, AI-driven insights, and patient management tools. Market share data, user numbers, and revenue are not publicly specified. Competitors include established telehealth providers and broader health-tech companies.
- Product Name: Syra Health Platform (Conceptual)
Market Dynamics
Industry Overview
The health-tech industry is experiencing rapid growth, driven by increasing demand for convenient and accessible healthcare, advancements in AI and digital technologies, and a growing focus on preventive care and chronic disease management. The telehealth segment, in particular, has seen significant expansion.
Positioning
Syra Health Corp. aims to position itself as a provider of integrated health-tech solutions, combining telehealth with AI to offer differentiated services. Its competitive advantage may lie in its ability to innovate and adapt to the evolving digital health landscape.
Total Addressable Market (TAM)
The global digital health market is projected to reach hundreds of billions of dollars in the coming years. Syra Health Corp. is positioned to capture a segment of this market through its specialized offerings in telehealth and AI-driven solutions.
Upturn SWOT Analysis
Strengths
- Focus on innovative health-tech solutions.
- Potential for scalability with digital platforms.
- Adaptability to emerging technologies like AI.
Weaknesses
- Limited public information on established products and revenue streams.
- As a potentially smaller player, may face challenges in market penetration.
- Dependence on technological advancements and regulatory changes.
Opportunities
- Growing adoption of telehealth and digital health services.
- Increasing investment in AI for healthcare applications.
- Partnerships with healthcare providers and institutions.
- Expansion into underserved healthcare markets.
Threats
- Intense competition from established tech and healthcare companies.
- Evolving regulatory landscape for digital health and data privacy.
- Cybersecurity risks and data breaches.
- Challenges in user adoption and trust.
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Doximity (DOCS)
- GoodRx Holdings (GDRX)
Competitive Landscape
Syra Health Corp. operates in a highly competitive digital health market. Its ability to differentiate through its AI integration and comprehensive platform will be crucial. Competitors often have established customer bases, larger R&D budgets, and stronger brand recognition.
Growth Trajectory and Initiatives
Historical Growth: Information on Syra Health Corp. Class A Common Stock's historical growth trends is not extensively published.
Future Projections: Future growth projections for Syra Health Corp. Class A Common Stock are not widely available from analyst estimates. Growth will likely depend on successful product development, market adoption, and strategic partnerships.
Recent Initiatives: Specific recent strategic initiatives are not publicly detailed, but typical initiatives for health-tech companies include product development, market expansion, and strategic collaborations.
Summary
Syra Health Corp. is a health-tech company aiming to leverage AI and telehealth for improved healthcare. While its innovative approach presents opportunities in a growing market, the company faces significant challenges from established competitors and needs to demonstrate a clear path to revenue generation and profitability. Investors should closely monitor its product development, market penetration, and financial performance.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Publicly available company information (e.g., press releases, investor relations websites if available)
- Financial data aggregators (for general industry trends and competitor information)
- Market research reports (for industry overviews and TAM)
Disclaimers:
This JSON output is a structured representation of available public information and general industry analysis. Specific financial data, market share figures, and detailed historical information for Syra Health Corp. Class A Common Stock may be limited. This information is not intended as investment advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Syra Health Corp. Class A Common Stock
Exchange NASDAQ | Headquaters Carmel, IN, United States | ||
IPO Launch date 2023-09-29 | Interim CEO, CFO, COO & Director Ms. Priya Prasad | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 57 | Website https://www.syrahealth.com |
Full time employees 57 | Website https://www.syrahealth.com | ||
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.